Breast Cancer Management

Future Medicine

Evaluation status available after sign-in

About the journal

Breast Cancer Management is an open-access journal published by Future Medicine in United Kingdom. It is listed in PUBMED according to the sources read. Declared publication charge: 1,415 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Future Medicine
ISSN
1758-1923 · 1758-1931
Country
United Kingdom
Access
Open access
Declared publication charge
1,415 USD

Index listings

  • PUBMED · 2012-05-01
Indexing
PUBMED
APC
1,415 USD
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2023
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

342

Last recorded publication year

2023

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

18

i10-index

38

From OpenAlex open data (CC0).

Editorial & policy3
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Identity & continuity1
Source type
journal
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
Show all subjects (50)
  • Breast Lesions and Carcinomas
  • Advanced Breast Cancer Therapies
  • Advanced Breast Cancer Therapies
  • Breast Lesions and Carcinomas
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Cancer Risks and Factors
  • Cancer Risks and Factors
  • Breast Implant and Reconstruction
  • Breast Implant and Reconstruction
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Estrogen and related hormone effects
  • Estrogen and related hormone effects
  • Cancer-related Molecular Pathways
  • Cancer survivorship and care
  • Cancer-related Molecular Pathways
  • Cancer survivorship and care
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • PI3K/AKT/mTOR signaling in cancer
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer and Skin Lesions
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer and Skin Lesions
  • PI3K/AKT/mTOR signaling in cancer
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Human auditory perception and evaluation
  • Diverse Scientific and Economic Studies
  • Human auditory perception and evaluation
  • Diverse Scientific and Economic Studies
  • Colorectal Cancer Screening and Detection
  • Cancer-related cognitive impairment studies
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Screening and Detection
  • Cancer-related cognitive impairment studies
  • Cancer Immunotherapy and Biomarkers
  • Male Breast Health Studies
  • Male Breast Health Studies
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: